BioSpecifics Technologies Corporation
35 Wilbur Street
Lynbrook
New York
11563-2358
United States
Tel: 516-593-7000
Fax: 516-593-7010
Website: http://www.biospecifics.com/
219 articles about BioSpecifics Technologies Corporation
-
BioSpecifics Technologies Corporation Reports Second Quarter 2016 Financial Results
8/10/2016
-
BioSpecifics Technologies Corporation To Report Second Quarter 2016 Financial Results On Tuesday, August 9, 2016
8/2/2016
-
BioSpecifics Technologies Corporation Announces Positive Top-Line Results From Phase 2 Trial Of CCH For Treatment Of Human Lipoma
6/13/2016
-
BioSpecifics Technologies Corporation To Present At The Jefferies 2016 Healthcare Conference
6/2/2016
-
BioSpecifics Technologies Corporation Announces Publication Of Encouraging Data For Uterine Fibroid Treatment With CCH In American Journal Of Obstetrics & Gynecology
5/31/2016
-
BioSpecifics Technologies Corporation To Present At The 2016 UBS Global Healthcare Conference
5/18/2016
-
BioSpecifics Technologies Corporation Reports First Quarter 2016 Financial Results
5/10/2016
-
BioSpecifics Technologies Corporation To Report First Quarter 2016 Financial Results On Tuesday, May 10, 2016
5/3/2016
-
BioSpecifics Technologies Corporation To Present At The 15th Annual Needham Healthcare Conference
4/6/2016
-
BioSpecifics Technologies Corporation Reports Fourth Quarter And Full Year 2015 Financial Results
3/14/2016
-
BioSpecifics Technologies Corporation To Present At The 28th Annual ROTH Conference
3/8/2016
-
BioSpecifics Technologies Corporation To Report Fourth Quarter And Full Year 2015 Financial Results On Monday, March 14, 2016
3/7/2016
-
BioSpecifics Technologies Corporation To Present At The 2016 BIO CEO & Investor Conference
2/1/2016
-
BioSpecifics Technologies Corporation To Present At The Noble Financial Capital Markets' NobleCon12
1/13/2016
-
BioSpecifics Technologies Corporation To Present At The Stifel 2015 Healthcare Conference
11/16/2015
-
BioSpecifics Technologies Corporation Reports Third Quarter 2015 Financial Results
11/9/2015
-
BioSpecifics Technologies Corporation Announces Partner Endo International Exercises Early Opt-In For XIAFLEX For Two New Indications
11/6/2015
-
BioSpecifics Technologies Corporation To Report Third Quarter 2015 Financial Results On Monday, November 9, 2015
11/2/2015
-
BioSpecifics Technologies Corporation Announces First Commercial Sale Of XIAFLEX For The Treatment Of Dupuytren's Contracture In Japan
9/21/2015
-
BioSpecifics Technologies Corporation Announces Presentations At Upcoming Investor Conferences
9/2/2015